和誉-B(02256)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

02256 和誉-B

已收盘 05-06 16:08:33

7.820

-0.130

-1.64%

最高8.030	最低7.760	成交量287.30万
今开7.950	昨收7.950	日振幅3.40%
总市值53.02亿	流通市值53.02亿	总股本6.78亿
成交额2,268万	换手率0.42%	流通股本6.78亿
市净率2.52	ROE1.44%	每股收益0.05
52周最高8.980	52周最低2.730	市盈率162.98
股息0.00	股息收益率0.00	ROA-0.64%

北京优虎网络科技有限公司

免责声明:香港交易所资讯服务有限公司、其控股公司及／或该等控股公司的任何附属公司均竭力确保所提供信息的准确和可靠度，但不能保证其绝对准确和可靠，且亦不会承担因任何不准确或遗漏而引起的任何损失或损害的责任（不管是否侵权法下的责任或合约责任又或其它责任）

{"stockData":{"symbol":"02256","market":"HK","secType":"STK","nameCN":"和誉-B","latestPrice":7.82,"timestamp":1746518913016,"preClose":7.95,"halted":0,"volume":2873000,"delay":0,"floatShares":678000000,"shares":678000000,"eps":0.04798141784277709,"marketStatus":"已收盘","change":-0.13,"latestTime":"05-06 16:08:33","open":7.95,"high":8.03,"low":7.76,"amount":22678190,"amplitude":0.033962,"askPrice":7.82,"askSize":2000,"bidPrice":7.81,"bidSize":2000,"shortable":0,"etf":0,"ttmEps":0.04299302715710665,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1746581400000},"marketStatusCode":5,"adr":0,"listingDate":1634054400000,"exchange":"SEHK","adjPreClose":7.95,"openAndCloseTimeList":[[1746495000000,1746504000000],[1746507600000,1746518400000]],"volumeRatio":1.310556,"lotSize":1000,"spreadScale":0,"tradeCurrency":"HKD"},"requestUrl":"/m/hq/s/02256","defaultTab":"news","newsList":[{"id":"2533973635","title":"和誉-B获董事会主席徐耀昌博士增持合计3万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2533973635","media":"格隆汇资讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2533973635?lang=zh_cn&edition=full","pubTime":"2025-05-06 20:52","pubTimestamp":1746535927,"startTime":"0","endTime":"0","summary":"紧随购买后，徐博士于合共80,017,980股股份中拥有权益，占于本公告日期公司全部已发行股份总数约11.77%。据徐博士告知，其对集团的业务前景及增长充满信心。在符合适用的法律及监管要求下，徐博士不排除会在适当时候进一步增持公司股份的可能性。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025050620521594ee04ed&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025050620521594ee04ed&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02256","LU2488822045.USD","BK1161"],"gpt_icon":0},{"id":"2533355686","title":"和誉-B(02256)获创始人徐耀昌增持3万股股份","url":"https://stock-news.laohu8.com/highlight/detail?id=2533355686","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2533355686?lang=zh_cn&edition=full","pubTime":"2025-05-06 20:46","pubTimestamp":1746535606,"startTime":"0","endTime":"0","summary":"智通财经APP讯，和誉-B 公布，公司创始人、执行董事、首席执行官兼公司董事会主席徐耀昌博士已于 2025年5月6日于公开市场购买合计3万股公司股份，平均价格为每股股份约港币7.96元，占公司全部已发行股份总数约0.0044%。在符合适用的法律及监管要求下，徐耀昌博士不排除会在适当时候进一步增持公司股份的可能性。根据购回股份计划，自 2025年3月3日至本公告日，公司已合计购回479.8万股股份，累计支付对价为3506万港币。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1289829.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["02256","LU2488822045.USD","BK1161"],"gpt_icon":0},{"id":"2533633252","title":"和誉-B(02256)5月6日斥资235.06万港元回购30万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2533633252","media":"智通财经","labels":["shareholding","buyback"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2533633252?lang=zh_cn&edition=full","pubTime":"2025-05-06 20:38","pubTimestamp":1746535089,"startTime":"0","endTime":"0","summary":"智通财经APP讯，和誉-B(02256)发布公告，该公司于2025年5月6日斥资235.06万港元回购30万股股份，每股回购价格为7.77-8.03港元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1289821.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,buyback","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["LU2488822045.USD","BK1161","02256"],"gpt_icon":0},{"id":"2532812587","title":"和誉-B(02256)5月2日斥资238.15万港元回购30万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2532812587","media":"智通财经","labels":["shareholding","buyback"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2532812587?lang=zh_cn&edition=full","pubTime":"2025-05-02 19:01","pubTimestamp":1746183667,"startTime":"0","endTime":"0","summary":"智通财经APP讯，和誉-B(02256)发布公告，于2025年5月2日，该公司斥资238.15万港元回购30万股。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1289064.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding,buyback","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1161","LU2488822045.USD","02256"],"gpt_icon":0},{"id":"2531657080","title":"和誉-B(02256)4月30日斥资76.93万港元回购10万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2531657080","media":"智通财经","labels":["shareholding","buyback"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2531657080?lang=zh_cn&edition=full","pubTime":"2025-04-30 18:57","pubTimestamp":1746010625,"startTime":"0","endTime":"0","summary":"智通财经APP讯，和誉-B(02256)发布公告，该公司于2025年4月30日斥资76.93万港元回购10万股。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1288518.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,buyback","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["02256","BK1161","LU2488822045.USD"],"gpt_icon":0},{"id":"2531083318","title":"和誉-B04月30日遭主力抛售16.3万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2531083318","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2531083318?lang=zh_cn&edition=full","pubTime":"2025-04-30 16:15","pubTimestamp":1746000920,"startTime":"0","endTime":"0","summary":"04月30日, 和誉-B股价跌0.13%，报收7.67元，成交金额1653.6万元，换手率0.32%，振幅2.47%，量比0.61。和誉-B今日主力资金净流出16.3万元，连续4日净流出，上一交易日主力净流出38万元。该股近5个交易日上涨0.52%，主力资金累计净流出88.3万元；近20日主力资金累计净流出2860.0万元，其中净流出天数为14日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250430170414a6ce9888&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250430170414a6ce9888&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU2488822045.USD","BK1161","02256"],"gpt_icon":0},{"id":"2530474875","title":"和誉-B(02256)4月28日斥资223.5万港元回购30万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2530474875","media":"智通财经","labels":["shareholding","buyback"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2530474875?lang=zh_cn&edition=full","pubTime":"2025-04-28 19:10","pubTimestamp":1745838637,"startTime":"0","endTime":"0","summary":"智通财经APP讯，和誉-B(02256)发布公告，于2025年4月28日斥资223.5万港元回购30万股。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1286578.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,buyback","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["02256","LU2488822045.USD","BK1161"],"gpt_icon":0},{"id":"2530493368","title":"和誉-B(02256)：和誉医药于2025年AACR大会展示ABSK112(EGFRexon20ins)、ABSK131(PRMT5*MTA)等四项最新突破性临床前研究成果","url":"https://stock-news.laohu8.com/highlight/detail?id=2530493368","media":"智通财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2530493368?lang=zh_cn&edition=full","pubTime":"2025-04-28 08:52","pubTimestamp":1745801542,"startTime":"0","endTime":"0","summary":"该等研究成果为ABSK131在MTAP纯合缺失的癌症中以单药或者联合治疗方案的临床开发提供了有力支持。此外， ABK-KRAS-1具有良好的成药性。因此ABK-KRAS-1可作为一款用于治疗携带 KRAS突变癌症的非常有前景的治疗候选药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1286069.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1515","BK1574","159938","LU2488822045.USD","02256","BK1161","MTA","09939","BK4188"],"gpt_icon":0},{"id":"2530746734","title":"和誉-B：于2025年AACR大会展示ABSK112(EGFR exon20ins)等四项最新突破性临床前研究成果","url":"https://stock-news.laohu8.com/highlight/detail?id=2530746734","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2530746734?lang=zh_cn&edition=full","pubTime":"2025-04-28 08:02","pubTimestamp":1745798576,"startTime":"0","endTime":"0","summary":"格隆汇4月28日丨和誉-B(02256.HK)发布公告，其在2025年4月25日至4月30日于美国伊利诺伊州芝加哥举行的2025年美国癌症研究协会大会上以壁报的形式发布了四项最新突破性的临床前研究结果。该等研究成果包括EGFR exon20ins抑制剂 ABSK112、PRMT5*MTA抑制剂ABSK131以及pan-KRAS抑制剂ABK-KRAS-1，以及一项研究KRAS G12C抑制剂潜在耐药机制的研究成果。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250428080257a6cae3ee&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250428080257a6cae3ee&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","LU2488822045.USD","02256"],"gpt_icon":0},{"id":"2530909573","title":"和誉-B(02256)4月25日斥资75.8万港元回购10万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2530909573","media":"智通财经","labels":["shareholding","buyback"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2530909573?lang=zh_cn&edition=full","pubTime":"2025-04-25 17:32","pubTimestamp":1745573549,"startTime":"0","endTime":"0","summary":"智通财经APP讯，和誉-B(02256)发布公告，于2025年4月25日，该公司斥资75.8万港元回购10万股。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1285051.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,buyback","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["LU2488822045.USD","02256","BK1161"],"gpt_icon":0},{"id":"2529679851","title":"和誉-B04月24日主力净流入160万元 散户资金抛售","url":"https://stock-news.laohu8.com/highlight/detail?id=2529679851","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2529679851?lang=zh_cn&edition=full","pubTime":"2025-04-24 16:16","pubTimestamp":1745482575,"startTime":"0","endTime":"0","summary":"04月24日, 和誉-B股价涨3.15%，报收7.87元，成交金额3309万元，换手率0.62%，振幅4.98%，量比0.82。和誉-B今日主力资金净流入160万元，上一交易日主力净流出175万元。该股近5个交易日上涨10.20%，主力资金累计净流入302万元；近20日主力资金累计净流出2683万元，其中净流出天数为12日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250424170031a6c6562b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250424170031a6c6562b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU2488822045.USD","BK1161","02256"],"gpt_icon":0},{"id":"2529574800","title":"和誉-B(02256)4月23日耗资约38.5万港元回购5.3万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2529574800","media":"智通财经","labels":["shareholding","buyback"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2529574800?lang=zh_cn&edition=full","pubTime":"2025-04-23 18:06","pubTimestamp":1745402798,"startTime":"0","endTime":"0","summary":"智通财经APP讯，和誉-B(02256)公布，2025年4月23日耗资约38.5万港元回购5.3万股股份。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1283198.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,buyback","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["02256","BK1161","LU2488822045.USD"],"gpt_icon":0},{"id":"2529519620","title":"和誉-B盘中异动 早盘急速上涨5.23%报7.440港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2529519620","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2529519620?lang=zh_cn&edition=full","pubTime":"2025-04-23 11:23","pubTimestamp":1745378580,"startTime":"0","endTime":"0","summary":"2025年04月23日早盘11时23分，和誉-B股票出现异动，股价大幅拉升5.23%。截至发稿，该股报7.440港元/股，成交量228.7万股，换手率0.34%，振幅3.68%。资金方面，该股资金流入976.604万港元，流出429.638万港元。和誉-B股票所在的生物技术行业中，整体涨幅为1.91%。该公司拥有两款核心候选产品ABSK011及ABSK091以及12款其他管线候选产品。ABSK091是一种分子靶向候选产品,是FGFR亚型1、2及3的高效及选择性抑制剂。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250423112300aa2c777b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250423112300aa2c777b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02256","LU2488822045.USD","BK1161"],"gpt_icon":0},{"id":"2529516590","title":"港股概念追踪|美国AACR  2025年会临近    机构关注创新药发展趋势（附概念股）","url":"https://stock-news.laohu8.com/highlight/detail?id=2529516590","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2529516590?lang=zh_cn&edition=full","pubTime":"2025-04-23 09:50","pubTimestamp":1745373032,"startTime":"0","endTime":"0","summary":"2025 年美国癌症研究协会年会将于当地时间2025年4月25日-30日在美国芝加哥举办。本次AACR年会上国清院展示8项临床前研究成果，包括多个全球首创的双抗、多抗及ADC的首次亮相。长江生命科技：公司将在美国芝加哥举行的美国癌症研究协会2025年度年会上，展示研发中癌症疫苗临床前研究最新数据。相关研究摘要将于美国东部时间2025年4月11日发表于AACR官方期刊《Cancer Research》。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1282904.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["02256","BK1574","BK4614","159992","LU2488822045.USD","YANG","00775","BK1161","BK1569","06978","HSTECH"],"gpt_icon":1},{"id":"2529271375","title":"和誉-B(02256)4月22日斥资141.19万港元回购20万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2529271375","media":"智通财经","labels":["shareholding","buyback"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2529271375?lang=zh_cn&edition=full","pubTime":"2025-04-22 18:25","pubTimestamp":1745317516,"startTime":"0","endTime":"0","summary":"智通财经APP讯，和誉-B(02256)发布公告，于2025年4月22日斥资141.19万港元回购股份20万股，每股回购价格为6.9-7.23港元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1282336.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,buyback","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1161","02256","LU2488822045.USD"],"gpt_icon":0},{"id":"2529684325","title":"和誉-B04月22日主力净流入363万元 散户资金抛售","url":"https://stock-news.laohu8.com/highlight/detail?id=2529684325","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2529684325?lang=zh_cn&edition=full","pubTime":"2025-04-22 16:15","pubTimestamp":1745309710,"startTime":"0","endTime":"0","summary":"04月22日, 和誉-B股价涨3.36%，报收7.07元，成交金额6435万元，换手率1.35%，振幅7.31%，量比2.01。和誉-B今日主力资金净流入363万元，上一交易日主力净流出0万元。该股近5个交易日上涨2.93%，主力资金累计净流入664万元；近20日主力资金累计净流出4195万元，其中净流出天数为13日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250422170509a6c3899e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250422170509a6c3899e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU2488822045.USD","BK1161","02256"],"gpt_icon":0},{"id":"2529631674","title":"和誉-B盘中异动 下午盘快速上涨5.26%","url":"https://stock-news.laohu8.com/highlight/detail?id=2529631674","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2529631674?lang=zh_cn&edition=full","pubTime":"2025-04-22 13:31","pubTimestamp":1745299870,"startTime":"0","endTime":"0","summary":"2025年04月22日下午盘13时31分，和誉-B股票出现波动，股价大幅拉升5.26%。和誉-B股票所在的生物技术行业中，整体涨幅为5.14%。和誉-B公司简介：和誉开曼有限责任公司是一家中国的临床阶段生物制药公司。该公司拥有两款核心候选产品ABSK011及ABSK091以及12款其他管线候选产品。ABSK091是一种分子靶向候选产品,是FGFR亚型1、2及3的高效及选择性抑制剂。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025042213311094ddab1c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025042213311094ddab1c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU2488822045.USD","02256","BK1161"],"gpt_icon":0},{"id":"2527247000","title":"和誉-B(02256)4月16日斥资405.62万港元回购60万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2527247000","media":"智通财经","labels":["shareholding","buyback"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2527247000?lang=zh_cn&edition=full","pubTime":"2025-04-16 22:59","pubTimestamp":1744815577,"startTime":"0","endTime":"0","summary":"智通财经APP讯，和誉-B(02256)发布公告，于2025年4月16日，该公司斥资405.62万港元回购60万股。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1279806.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding,buyback","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["02256","LU2488822045.USD","BK1161"],"gpt_icon":0},{"id":"2527610664","title":"和誉-B04月15日主力净流出170万元 散户资金买入","url":"https://stock-news.laohu8.com/highlight/detail?id=2527610664","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2527610664?lang=zh_cn&edition=full","pubTime":"2025-04-15 16:16","pubTimestamp":1744704975,"startTime":"0","endTime":"0","summary":"04月15日, 和誉-B股价跌0.56%，报收7.16元，成交金额2856万元，换手率0.58%，振幅7.22%，量比0.51。和誉-B今日主力资金净流出170万元，上一交易日主力净流入517万元。该股近5个交易日上涨13.05%，主力资金累计净流出756万元；近20日主力资金累计净流出1906万元，其中净流出天数为13日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250415171347a6bb0459&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250415171347a6bb0459&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU2488822045.USD","BK1161","02256"],"gpt_icon":0},{"id":"2527186921","title":"和誉-B04月14日主力净流入517万元 散户资金抛售","url":"https://stock-news.laohu8.com/highlight/detail?id=2527186921","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2527186921?lang=zh_cn&edition=full","pubTime":"2025-04-14 16:15","pubTimestamp":1744618550,"startTime":"0","endTime":"0","summary":"04月14日, 和誉-B股价涨5.42%，报收7.20元，成交金额3202万元，换手率0.66%，振幅5.86%，量比0.47。和誉-B今日主力资金净流入517万元，上一交易日主力净流出359万元。该股近5个交易日上涨16.32%，主力资金累计净流出575万元；近20日主力资金累计净流出1778万元，其中净流出天数为13日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250414170800a4584a2a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250414170800a4584a2a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU2488822045.USD","BK1161","02256"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.abbisko.com","stockEarnings":[{"period":"1week","weight":0.0474},{"period":"1month","weight":-0.0479},{"period":"3month","weight":0.6494},{"period":"6month","weight":0.8445},{"period":"1year","weight":1.3246},{"period":"ytd","weight":0.7283}],"compareEarnings":[{"period":"1week","weight":0.0238},{"period":"1month","weight":-0.0301},{"period":"3month","weight":0.1127},{"period":"6month","weight":0.0974},{"period":"1year","weight":0.236},{"period":"ytd","weight":0.1219}],"compareStock":{"symbol":"HSI","name":"恒生指数"},"description":"和誉开曼有限责任公司是一家中国的临床阶段生物制药公司。该公司致力于发现及开发创新且差异化的小分子肿瘤疗法。该公司拥有两款核心候选产品ABSK011及ABSK091以及12款其他管线候选产品。ABSK011是一种有效的高选择性小分子成纤维细胞生长因子受体4（FGFR4）抑制剂。ABSK091是一种分子靶向候选产品，是FGFR亚型1、2及3的高效及选择性抑制剂。该公司的产品主要用于治疗肝细胞癌（HCC）、尿路上皮癌（UC）及胃癌（GC）。","yearOnYearQuotes":[{"month":1,"riseRate":0.25,"avgChangeRate":-0.143011},{"month":2,"riseRate":0.75,"avgChangeRate":0.046576},{"month":3,"riseRate":0.5,"avgChangeRate":0.054417},{"month":4,"riseRate":0.25,"avgChangeRate":-0.010041},{"month":5,"riseRate":0.25,"avgChangeRate":-0.023754},{"month":6,"riseRate":0.333333,"avgChangeRate":-0.013147},{"month":7,"riseRate":0.666667,"avgChangeRate":0.049332},{"month":8,"riseRate":0.333333,"avgChangeRate":-0.050943},{"month":9,"riseRate":0.666667,"avgChangeRate":0.042883},{"month":10,"riseRate":0.666667,"avgChangeRate":0.004984},{"month":11,"riseRate":0.75,"avgChangeRate":0.204437},{"month":12,"riseRate":0,"avgChangeRate":-0.093315}],"exchange":"SEHK","name":"和誉-B","nameEN":"ABBISKO-B"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.33.2","shortVersion":"4.33.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"和誉-B(02256)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供和誉-B(02256)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"和誉-B,02256,和誉-B股票,和誉-B股票老虎,和誉-B股票老虎国际,和誉-B行情,和誉-B股票行情,和誉-B股价,和誉-B股市,和誉-B股票价格,和誉-B股票交易,和誉-B股票购买,和誉-B股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"和誉-B(02256)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供和誉-B(02256)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}